Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Serum uric acid: Novel prognostic factor in primary systemic amyloidosis
Mayo Clinic Proceedings, 03/06/08
Kumar S et al. - The data presented in this study confirm the prognostic utility of cardiac troponin T (cTnT) and N-terminal propeptide of brain-type natriuretic peptide (NTProBNP) in a large group of patients and highlight the value of serum uric acid (UA) in allowing better forecasting of probable outcomes for patients with amyloidosis (AL).
Methods- Aim was to determine the prognostic value of serum UA in pts with primary systemic AL
- A cohort of 1977 pts with newly diagnosed AL, and 293 pts with AL who underwent peripheral blood stem cell transplant were studied retrospectively to examine the value of serum UA
- The prognostic value of several variables was examined, and the survival time was estimated
- Pts with UA levels greater than 8 mg/dL had a median OS of 9 mos from diagnosis vs. 20.3 mos for the remaining pts
- The prognostic value of UA was independent of the known cardiac prognostic markers cTnT and NTProBNP
- Pts with none, 1, 2, or 3 of these risk factors (UA, >8 mg/dL; cTnT, >0.035 ng/mL; and NTProBNP, >332 pg/mL) had a median OS of 36.6, 29.2, 11.1, and 3.6 mos, respectively
- Similarly, UA levels helped predict OS in pts undergoing peripheral blood stem cell transplant for AL and added to the value of cTnT and NTProBNP
Related Articles
A case with rheumatoid arthritis and systemic reactive AA amyloidosis showing rapid regression of amyloid deposition on gastroduodenal mucosa after a combined therapy of corticosteroid and etanercept
Rheumatology International, 10/16/09
Relevance Score: 69%
Vitreous Amyloidosis in Two Sisters as the Indication of Transthyretin-Related Familial Form of Systemic Amyloidosis Among Liver Transplantation Candidates
Transplantation Proceedings, 11/12/09
Relevance Score: 67%
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 47%
Prevention of Amyloidosis in Familial Mediterranean Fever with Colchicine: A Case-Control Study in Armenia
Medical Principles and Practice, 10/05/09
Relevance Score: 47%
Ten cases of systemic lupus erythematosus related to hepatitis B vaccine
Lupus, 11/09/09
Relevance Score: 46%
Today in Amyloidosis...keeping you current
Receive free subspecialty "5-minute updates" via email
Amyloid and the GI tract
Expert Review of Gastroenterology & Hepatology, 12/03/09
MEFV mutations in Egyptian patients suffering from familial Mediterranean fever: analysis of 12 gene mutations
Rheumatology International, 10/16/09
Classification of amyloidosis by laser microdissection and mass spectrometry based proteomic analysis in clinical biopsy specimens
Blood, 10/09/09
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
IgM, IgG, and IgA anti-DNA topoisomerase I antibodies in systemic sclerosis
Journal of Clinical Laboratory Analysis, 12/04/09
Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Journal of the European Academy of Dermatology and Venereology, 12/03/09
Role of Imaging in Spine, Hand, and Wrist Osteoarthritis
Rheumatic Disease Clinics of North America, 12/01/09
Sponsor
Article Search
Sponsor


See Latest Articles


